2022 annual financial data
Alaunos Therapeutics 2022 Operating margin
Direct answer
Operating margin was -1,201.4%.
Operating income was -35,105,000 USD and net income was -37,730,000 USD.
Operating cash flow was -29,232,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,922,000 USD
- Operating income
- -35,105,000 USD
- Net income
- -37,730,000 USD
- Operating cash flow
- -29,232,000 USD